Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference112 articles.
1. Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques;Keler;J Immunol,2003
2. A molecular perspective of CTLA-4 function;Teft;Annu Rev Immunol,2006
3. Sequence, structure, function, immunity: structural genomics of costimulation;Chattopadhyay;Immunol Rev,2009
4. CTLA-4 trafficking and surface expression;Valk;Trends Immunol,2008
5. CD28 and CTLA-4 coreceptor expression and signal transduction;Rudd;Immunol Rev,2009
Cited by 127 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic Treatment Options for In-Transit Metastases from Melanoma;Cancers;2024-09-03
2. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05
3. Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance;Frontiers in Immunology;2024-08-05
4. ELISA assay for the quantification of ipilimumab in human serum, plasma, milk, and cerebrospinal fluid;Journal of Pharmaceutical and Biomedical Analysis;2024-08
5. Advancements in Melanoma Therapies: From Surgery to Immunotherapy;Current Treatment Options in Oncology;2024-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3